Related Experiment Video
Updated: Dec 24, 2025
05:08
Targeted and Selective Treatment of Pluripotent Stem Cell-derived Teratomas Using External Beam Radiation in a Small-animal Model
Published on: February 17, 2019
6.5K
StarD13: a potential star target for tumor therapeutics
Leila Jaafar1, Zeinab Chamseddine1, Mirvat El-Sibai2
1Department of Natural Sciences, School of Arts and Sciences, Lebanese American University, Chouran, P.O. Box 13-5053, 1102 2801, Beirut, Lebanon.
Human Cell
|April 11, 2020
Summary
StarD13 functions as a tumor suppressor by regulating cell survival and apoptosis. Its downregulation in tumors impacts Rho GTPase activity, affecting metastasis and offering potential therapeutic strategies.
Area of Science:
- Molecular Biology
- Oncology
- Cell Biology
Background:
- StarD13 acts as a GTPase activating protein (GAP) for Rho GTPases.
- It regulates cell survival and apoptosis pathways, both p53-dependent and independent.
- StarD13 is frequently downregulated or inhibited in various tumor types.
Purpose of the Study:
- To review the key characteristics of the StarD13 protein.
- To elucidate the role of StarD13 in tumor malignancies.
- To highlight StarD13 as a potential therapeutic target.
Main Methods:
- Literature review of StarD13 function and expression in cancer.
- Analysis of StarD13's impact on Rho GTPase signaling.
- Examination of StarD13's influence on cellular adhesion and actin dynamics.
Main Results:
- StarD13 downregulation affects Rho GTPase signaling, impacting cell adhesion and actin dynamics.
- Altered dynamics contribute to variable effects on tumor metastasis based on tumor type and grade.
- StarD13's tumor suppressor role is linked to its regulation of apoptosis.
Conclusions:
- StarD13 is a critical regulator of cell survival and a tumor suppressor.
- Its dysregulation in cancer contributes to altered cellular dynamics and metastasis.
- StarD13 represents a promising candidate for novel cancer therapeutic strategies.
Related Concept Videos
02:57Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
01:27Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
02:56Treatment Resistant Cancers
3.6K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.6K
02:07Tumor Progression
7.1K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.1K
02:40Cancer Stem Cells and Tumor Maintenance
5.8K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.8K
02:49Cancer Therapies
9.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.7K